Fundraising Fox
/Companies
Sign in

GammaTile

8 known investors

Find your way into GammaTile

Sign up to see every warm intro you have to GammaTile

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the GammaTile team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells. It is indicated for patients with operable, newly diagnosed and recurrent brain tumors such as glioblastoma, brain metastases, and meningiomas.

BiotechHealthtechMedical Devices

Founders & leadership

DGDavid G. Brachman, MD, FASTRO
David G. Brachman, MD, FASTROCo-Founder and Chief Technology Officer
HM
Heyoung McBride, MD, MS, FASTROCo-Founder
PNPeter Nakaji, MD
Peter Nakaji, MDCo-FounderPeter Nakaji, MD is a neurosurgeon and executive director at Scottsdale Neurosurgery Specialists, and a professor at the University of Arizona College of Medicine – Phoenix and the ASU John Shufeldt School of Medicine and Medical Engineering. He chaired the neurosurgery department at UA College of Medicine – Phoenix and directed Banner Health's Neuroscience Institute from 2019 to 2025, following years of practice with Barrow Neurosurgical Associates and St. Joseph's Hospital and Medical Center.
EY
Emad Youssef, MDCo-Founder
TTTheresa Thomas, MS, CCRC
Theresa Thomas, MS, CCRCCo-Founder
PLPer Langoe
Per LangoeChief Executive OfficerPer Langoe is Chief Executive Officer of GT Medical Technologies, Inc., a role he took on in 2024. He previously served as President and CEO of Palette Life Sciences, chairman of the board at ProstaLund AB and AdvaVet, a partner at Langoe Strategic Advisors, and head of M&A for Nestlé Skin Health.

Investors · 8

BlueStone Venture PartnersreportedTucson · $250K – $1M

How we know: funding news · press coverage · Not right? Tell us

Evidity Health CapitalreportedNew York · $5M

How we know: medtechdive.com · Not right? Tell us

FemHealth VenturesreportedShort Hills

How we know: medtechdive.com · Not right? Tell us

Gilde HealthcarereportedUtrecht · $1.1M – $55M

How we know: funding news · medtechdive.com · Not right? Tell us

MedTech Venture PartnersreportedMenlo Park

How we know: funding news · medtechdive.com · Not right? Tell us

MVM Life Science PartnersreportedLondon · $20M – $100M

How we know: funding news · medtechdive.com · Not right? Tell us

Viking GlobalreportedStamford

How we know: medtechdive.com · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does GammaTile do?
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells. It is indicated for patients with operable, newly diagnosed and recurrent brain tumors such as glioblastoma, brain metastases, and meningiomas.
Who founded GammaTile?
GammaTile was founded by David G. Brachman, MD, FASTRO, Heyoung McBride, MD, MS, FASTRO, Peter Nakaji, MD, Emad Youssef, MD, Theresa Thomas, MS, CCRC.
Who are GammaTile's investors?
GammaTile's investors include Accelmed Partners, BlueStone Venture Partners, Evidity Health Capital, FemHealth Ventures, Gilde Healthcare, MedTech Venture Partners, MVM Life Science Partners, Viking Global.